EPO, erythropoietin; Hb, hemoglobin; s.c., subcutaneous; t.i.w., three times a week. a Hb response is defined as an Hb increase of 2 g/dl from baseline if not stated otherwise. b Hb target level ...

Panelists discuss how the final efficacy and safety analysis from the COMMANDS trial (Della Porta et al, Lancet 2024) highlights the role of luspatercept in first-line treatment for lower-risk ...

Columbus staked its claim as a tennis town by winning both the girls and boys State Singles championships. Wilson, who now ...

The Racing Medication and Testing Consortium granted interim accreditation to the University of Kentucky Equine Analytical ...

Every year is a busy one in Maine sports. Between all the high school, college and minor league pro teams, something is always going on. When I started in this business 25 years ago, friends would ask ...

“On-target toxicities of PHD inhibitors are well-documented and can be monitored through established biomarkers such as erythropoietin (EPO) and vascular endothelial growth factor (VEGF ...

Based Roundtable® event, Andrew M. Brunner, MD, discussed dosing strategy for erythropoiesis-stimulating agents as well as ...

However, they have yet to make good on this promise. To date, more than 40 biosimilars have launched in Europe, including: epoetin (EPO), insulin, human growth hormone (hGF), granulocyte-colony ...